Tom Valuck, MD, JD

Quality Outlook

Catch Me If You Can: Aligning Quality Measurement With Oncology Innovation

11/22/2019

Tom Valuck, MD, JD, and colleagues of Discern Health, part of Real Chemistry, highlight the challenge that physicians face with integrating rapid science advances into practice while payers pressure them to improve value.

Tom Valuck, MD, JD, and...

11/22/2019

Journal of Clinical Pathways

Research Reports

Impact of Shared Decision-Making and Patient Decision Aids on Health Care Cost and Utilization in the US: A Systematic Review

12/05/2022

Theresa Schmidt , MA, PMP, CSPO;

Robert W. Dubois , MD, PhD;

Jacqlyn Riposo , MBA;

Kimberly Westrich , MA;

Palak Patel , MHA;

Tom Valuck , MD, JD;

Brittany Perkins , MPH;

The authors summarize evidence on the impact of shared decision-making as a process, patient decision aids as tools to support decision-making, and the combination of shared decision-making and patient decision aids on cost, utilization, and...

The authors summarize evidence...

12/05/2022

Journal of Clinical Pathways

Quality Outlook

We Need Better Quality Measures for Oncology Care First

01/24/2020

Manasi A. Tirodkar , PhD, MS;

David Blaisdell , BA;

Tom Valuck , MD, JD;

Tom Valuck, MD, JD, and colleagues of Discern Health, part of Real Chemistry, argue that if the Oncology Care First model proposed by CMS is adopted as proposed, CMS will be missing a critical opportunity to advance quality measurement for...

Tom Valuck, MD, JD, and...

01/24/2020

Journal of Clinical Pathways

Quality Outlook

Quality Measures for Medicare’s Enhancing Oncology Model (EOM): New and Improved or More of the Same?

01/26/2023

David Blaisdell , BA;

Tom Valuck , MD, JD;

Sarena Ho , MSPH;

This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...

This blog discusses the Center...

01/26/2023

Journal of Clinical Pathways

Quality Outlook

Sound Check: Listening More Closely to Oncology Patients

03/24/2020

Manasi A. Tirodkar , PhD, MS;

David Blaisdell , BA;

Tom Valuck , MD, JD;

Theresa Schmidt , MA, PMP, CSPO;

Tom Valuck, MD, JD, and colleagues explore whether patient-reported measure sets and patient-reported performance measures truly represent oncology patients’ feedback and needs.

Tom Valuck, MD, JD, and...

03/24/2020

Journal of Clinical Pathways

Quality Outlook

Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model

06/08/2023

Tom Valuck , MD, JD;

Jacqlyn Riposo , MBA;

This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...

This blog discusses the Centers...

06/08/2023

Journal of Clinical Pathways

Quality Outlook

Recognizing and Testing Telehealth Models in Oncology Care First

02/09/2021

David Blaisdell , BA;

Tom Valuck , MD, JD;

Theresa Schmidt , MA, PMP, CSPO;

In this blog, Tom Valuck, MD, JD, and colleagues explore ways for CMS to incorporate telehealth in oncology alternative payment models.

In this blog, Tom Valuck, MD,...

02/09/2021

Journal of Clinical Pathways

Perspectives

Leveraging Quality Measurement to Drive Equitable Cancer Care for Transgender Individuals

08/07/2023

Theresa Schmidt , MA, PMP, CSPO;

Tom Valuck , MD, JD;

Don S. Dizon , MD;

Nina Regenold , MSc;

Will Nolan ;

Elizabeth Donckels , MSPH;

Elizabeth Donckels, MSPH, and colleagues investigate several measurement tactics to promote cancer care quality improvement for transgender individuals.

Elizabeth Donckels, MSPH, and...

08/07/2023

Journal of Clinical Pathways

Viewpoint

Catch Me If You Can: Aligning Quality Measurement With Oncology Innovation

12/17/2019

Tom Valuck , MD, JD;

Theresa Schmidt , MA, PMP, CSPO;

David Blaisdell , BA;

Breakthrough treatments in cancer care, including precision therapies tailored to specific patient factors, are driving rapid changes in the definitions of oncology quality and value. Efforts to implement value-based...

...

12/17/2019

Journal of Clinical Pathways

Quality Outlook

Is Social Media Engagement Empowering or Dangerous for Cancer Patients and Their Caregivers?

06/14/2021

Theresa Schmidt , MA, PMP, CSPO;

Tom Valuck , MD, JD;

Justin Kerley , BA;

Justin Kerley, BA, and Theresa Schmidt, MA, PMP, CSPO, explore the dynamics of patient and caregiver engagement via social media and consider how quality measures and other quality tools can help maximize the benefits of social media while...

Justin Kerley, BA, and Theresa...

06/14/2021

Journal of Clinical Pathways